Rendering

Component: (Network and Table)
Network
2310301 - Disclosure - INCOME TAXES (Tables)
(http://kitepharma.com/role/IncomeTaxesTables)
Table(Implied)
Slicers (applies to each fact value in each table cell)
Income Tax Disclosure [Abstract]Period [Axis]
2016-01-01 - 2016-12-31
Income Tax Disclosure [Abstract]
 
Composition of Income Tax (Expense) Benefit from Continuing Operations
The composition of our income tax expense (benefit) from continuing operations for the years ended December 31, 2016, 2015, and 2014, was as follows (in thousands):

 
Current
 
Deferred
 
Total
Year ended December 31, 2016
 
 
 
 
 
U.S. Federal
$

 
$

 
$

State
1

 

 
1

Foreign

 
(2,895
)
 
(2,895
)
Total
1

 
(2,895
)
 
(2,894
)
Year ended December 31, 2015
 
 
 
 
 
U.S. Federal
$

 
$

 
$

State
1

 

 
1

Foreign

 

 

Total
1

 

 
1

Year ended December 31, 2014
 
 
 
 
 
U.S. Federal
$

 
$

 
$

State
1

 

 
1

Foreign

 

 

Total
1

 

 
1

 
 
Reconciles of Income Tax Rate from Continuing Operations to the Federal Statutory Tax Rate
The following table reconciles the Company's effective income tax rate from continuing operations to the federal statutory tax rate of 34%:
 
YEAR ENDED DECEMBER 31,
 
2016
 
2015
 
2014
Federal income taxes
34.00
 %
 
34.00
 %
 
34.00
 %
State income taxes, net of federal benefit
6.17
 %
 
3.77
 %
 
5.08
 %
Foreign rate differential
(14.69
)%
 
(3.51
)%
 
 %
Meals and entertainment
(0.03
)%
 
(0.04
)%
 
(0.06
)%
Stock Compensation
(0.55
)%
 
(2.27
)%
 
(4.41
)%
Non-cash interest
 %
 
 %
 
(0.53
)%
Net operating losses expiring due to Section 382 limitation
 %
 
(1.36
)%
 
 %
Return to provision difference
(0.07
)%
 
(0.21
)%
 
 %
ASC 740-10
(4.07
)%
 
(8.11
)%
 
 %
Other permanent differences
0.17
 %
 
0.13
 %
 
 %
Change in valuation allowance
(19.86
)%
 
(22.40
)%
 
(28.85
)%
Prior period true up
 %
 
 %
 
(5.23
)%
Income tax benefits from continuing operations
1.07
 %
 
 %
 
 %
 
 
Components of Deferred Tax Assets
As of December 31, 2016 and 2015, the tax effects of temporary differences that gave rise to significant portions of deferred tax assets and deferred tax liabilities were: 
 
DECEMBER 31,
 
2016
 
2015
Deferred tax assets - noncurrent:
 
 
 
Deferred rent
$
2,305

 
$
754

Net operating loss and other carryforwards
66,702

 
5,582

Stock compensation
34,129

 
14,974

Accrued compensation
5,236

 
2,234

Deferred revenue
14,883

 
21,205

Collaboration agreements
6,485

 

Other
679

 
351

Less: valuation allowance
(111,835
)
 
(40,164
)
Total deferred tax assets - noncurrent
18,584

 
4,936

Deferred tax liabilities - noncurrent:
 
 
 
Section 481 adjustment
(1,319
)
 
(19
)
Fixed assets
(2,334
)
 
(1,254
)
Intangible assets
(1,682
)
 
(3,201
)
Deferred state taxes
(13,249
)
 
(3,307
)
Total deferred tax liabilities - noncurrent
(18,584
)
 
(7,781
)
Net deferred tax assets/(liabilities) - noncurrent
$

 
$
(2,845
)
 
 
Summary of Activity Related to Unrecognized Tax Benefit
The following table summarizes the activity related to uncertain tax benefits for 2016, 2015, and 2014, excluding any interest or penalties:

 
FOR THE YEAR ENDED DECEMBER 31,
 
2016
 
2015
 
2014
Balance as of January 1
$
10,392

 
$

 
$

Gross increases - tax positions in prior periods
1,379

 

 

Gross decreases - tax positions in prior periods
(2,143
)
 

 

Gross increases - tax positions in current periods
9,628

 
10,392

 

Gross decreases - tax positions in current periods

 

 

Net unrecognized tax benefits as of December 31
$
19,256

 
$
10,392

 
$